Our advisory boards are composed of key opinion leaders and experts in the fields of neurodegenerative diseases, dementia, aging and neurobiochemistry. Our advisors enhance our ability to identify and evaluate product opportunities, conduct well-designed clinical trials that meet regulatory agency guidelines, and stay abreast of new developments in research.

Our Clinical Advisory Board

Steven H. Ferris, Ph.D. | Chairman

Dr. Steven H. Ferris is Chairman of the Accera Clinical Advisory Board, a Gerald & Dorothy Friedman Professor of the New York University Alzheimer's Disease Center, and Executive Director of the Silberstein Institute for Aging and Dementia at the NYU School of Medicine. In this capacity he leads a staff of 30 persons that have conducted more than 40 sponsored clinical drug trials in aging and Alzheimer's disease (AD). Dr. Ferris is a recognized leader in the development of neuropsychometric tests for memory and cognition that are used worldwide for clinical testing of AD drugs and approval by regulatory agencies. During his distinguished career he has authored more than 175 scientific publications and served on the editorial boards of numerous journals on aging and dementia. Dr. Ferris was awarded a Ph.D. in Experimental Psychology by City University of New York.

Martin R. Farlow, M.D.

Dr. Martin R. Farlow is Vice Chairman of Research and Professor in Neurology at the Indiana University School of Medicine, and Director of the Clinical Core of the Alzheimer's Disease Clinic. His clinical research focuses primarily on Alzheimer's disease, therapeutic treatments for various dementias, and effective diagnosis of memory and cognitive loss secondary to Alzheimer's disease. Dr. Farlow has conducted greater than 100 clinical trials in Alzheimer's disease and other dementias. He is a highly regarded lecturer on the treatment and care of patients with Alzheimer's disease. His research has led to more than 250 publications and he currently serves on the editorial boards of numerous journals related to aging, dementia and research. Dr. Farlow received his medical education at Indiana University.

Our Scientific Advisory Board

Leif Hertz, M.D., D.Sc.

Dr. Leif Hertz is Professor Emeritus in the Department of Pharmacology at University of Saskatchewan. He is an expert on energy metabolism in the brain, neuronal�astrocytic interactions and the biochemical characteristics of memory formation. Dr. Hertz has more than 320 scientific publications and has served on the editorial boards of five prestigious journals of neuroscience. He has held continuous grants from the Medical Research Council of Canada and has received numerous awards for his achievements in neurochemistry research. Dr. Hertz received his M.D. from University of Copenhagen and D.Sc. from University of Odense.

Thomas E. Johnson, Ph.D.

Dr. Thomas E. Johnson is Professor of Molecular Behavioral Genetics at the University of Colorado. He is one of the world's leading experts on the molecular genetic basis of aging and diseases of aging and has authored more than 230 scientific publications. He serves on the Board of Directors for the American Aging Association, the National Scientific Advisory Council for the American Federation for Aging Research and was recently an Ellison Medical Foundation Senior Scholar. Dr. Johnson has served on the editorial review board for a number of scientific publications including section editor for the Journal of Neurobiology of Aging and Associate Editor for the Journal of Experimental Gerontology. He received his B.Sc. degree from M.I.T. and Ph.D. in genetics from University of Washington.